Insurance Firm Becomes High-Risk Private Lender

For most of its history, Delaware Life was the kind of insurance company that drew little attention — a mid-size annuity provider with a balance sheet that looked much like any other U.S. life insurer. Then Mark Walter, best known as owner of the Los Angeles Dodgers and a principal at Guggenheim Partners, steered it in a different direction. Under his influence, Delaware Life insurance private credit exposure grew dramatically, transforming a conventional carrier into something closer to a shadow bank operating behind a state insurance license.

That transformation, reported by The Wall Street Journal, raises questions that extend well beyond one company's balance sheet.

How an Obscure Insurer Quietly Pivoted to High-Risk Private Lending

The shift at Delaware Life did not happen through a dramatic announcement. It happened gradually, through portfolio decisions that moved the company away from the investment-grade bonds that dominate most life insurer balance sheets toward a heavier concentration of riskier, less liquid private-credit instruments.

Traditional U.S. life insurers hold roughly 90% or more of their invested assets in investment-grade securities, according to data compiled annually by the National Association of Insurance Commissioners. That figure reflects decades of regulatory design: insurance companies are stewards of policyholder premiums, and capital requirements are calibrated to match the credit quality of their holdings.

Delaware Life's pivot broke from that convention. Rather than a portfolio anchored in highly rated corporate bonds, Treasuries, and agency securities, the company built a much heavier concentration in private credit — loans originated outside the public debt markets, often to borrowers who cannot access investment-grade financing.

What Makes This Strategy Different From Traditional Insurance Investing

Private credit is not inherently disqualifying for an insurance portfolio. Many large carriers hold modest allocations as a yield enhancement. The issue at Delaware Life is concentration — the degree to which the portfolio diverged from sector norms.

Standard insurance investment practice follows what actuaries call asset-liability matching: the duration, credit quality, and liquidity of investments should correspond to the nature of policyholder obligations. Long-duration liabilities, like annuities that pay out over decades, are typically backed by long-duration investment-grade bonds. Private loans, by contrast, are illiquid by definition. Secondary markets are thin. Valuations can be opaque. When a policyholder needs a payout, the insurer must have liquid assets to cover it — not a portfolio of loans that cannot be quickly sold.

Delaware Life insurance private credit holdings represent a meaningful departure from this principle. The company was not allocating a diversifying sliver of its portfolio to private loans; it was building a business model around them. That distinction matters enormously to regulators and to the policyholders whose premiums fund the strategy.

The Risk Profile: Why Regulators Are Watching

State insurance regulators assess carrier health primarily through risk-based capital ratios, a framework developed and maintained by the NAIC. The model assigns capital charges to each asset class based on its risk profile — higher-risk assets require proportionally larger capital reserves. A company that tilts heavily toward lower-rated or illiquid instruments will see its required capital buffer rise accordingly.

The critical threshold in NAIC guidelines is the company action level, triggered when an insurer's RBC ratio falls below 200% of the authorized control level. Below 100%, regulators can take control of the company outright.

For Delaware Life, the relevant question is whether RBC charges adequately capture the actual risk embedded in a heavy private-credit book. Critics argue they do not. Private loans are often rated by internal models rather than public agencies, creating the possibility that asset risk is systematically understated in regulatory filings.

Credit rating agencies — Moody's, S&P, and Fitch — have developed their own frameworks for assessing insurers with elevated private-credit exposure. Their methodologies examine not just headline credit quality but concentration risk, valuation methodology, and the degree to which a carrier depends on internal ratings from affiliated entities. An insurer that both originates loans and rates them faces conflicts that third-party analysts consistently flag as governance risk. Delaware Life insurance private credit strategy is precisely the arrangement those methodologies are designed to scrutinize.

The Broader Trend: Insurance Capital Flowing Into Private Markets

Delaware Life is not alone. Since the post-2008 low-rate era compressed yields on traditional fixed-income assets, private equity and alternative asset managers have viewed insurance balance sheets as a source of permanent, low-cost capital. The playbook: acquire or partner with a carrier, redirect premium income into higher-yielding private loans, and capture the spread.

Apollo Global Management's ownership of Athene is the highest-profile example. Blackstone, KKR, and Carlyle have pursued similar structures across different carriers. The Delaware Life case reflects the same logic applied by Guggenheim-connected principals.

The appeal is real. Policyholders who purchased fixed annuities benefit from higher credited rates when insurers earn more on their portfolios. The question is whether those higher yields adequately compensate for the risks being absorbed — and whether policyholders understand the risk transformation occurring inside their carrier's balance sheet. NAIC data consistently shows that the life insurance sector overall maintains strong investment-grade concentrations. When a single carrier diverges sharply from that norm, it stands out.

What This Means for Regulatory Frameworks

The regulatory architecture governing U.S. insurance was not designed for this business model. State-level oversight, while robust in many respects, creates gaps when a carrier's investment strategy is directed by an affiliated asset manager with its own return targets and fee incentives.

Three structural gaps warrant attention. First, RBC models lag private-market innovation — calibrating capital charges for bespoke private loans remains difficult when valuation data is sparse and inconsistent. Second, affiliated-transaction rules exist in every state but enforcement depends on disclosure, and disclosure of complex inter-affiliate loan arrangements is notoriously difficult to parse. Third, the concentration of Delaware Life insurance private credit exposure relative to peers is precisely the kind of anomaly that actuarial reviews and market conduct examinations should surface — but only if examiners have adequate tools and resources.

Federal involvement is limited: insurance regulation remains state-based. The Financial Stability Oversight Council has authority to designate systemically important non-bank financial institutions, but that threshold carries significant political friction. What regulators can do — and should do — is require clearer disclosure of private-credit concentration, mandate independent third-party valuation of illiquid assets, and ensure that RBC filings reflect actual credit quality rather than internal ratings from affiliated originators.

Key Takeaways for Investors and Policyholders

Delaware Life insurance private credit concentration is a case study in what happens when yield-seeking behavior, enabled by a prolonged low-rate environment, collides with the conservative mandates that define insurance regulation.

For annuity holders: the financial strength rating of your insurer matters. Check current ratings from A.M. Best, Moody's, or S&P. Annual statement filings, publicly available through your state's department of insurance, disclose portfolio composition in detail.

For investors watching the sector: Delaware Life is a leading indicator, not an outlier. Several carriers have quietly shifted toward similar models, and sector-wide divergence from traditional investment-grade norms deserves sustained scrutiny as private-credit performance cycles become clearer.

For regulators: individual company examinations catch problems after they develop. Proactive monitoring of portfolio concentration relative to peer benchmarks — with particular scrutiny for carriers whose investment strategy is directed by affiliated alternative asset managers — needs to become standard practice.

The fiduciary duty that insurers owe policyholders has not changed. What has changed is how much ingenuity is being applied to testing its limits.

Source: WSJ.com: Markets